Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Vet Comp Oncol ; 21(4): 587-594, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37464904

ABSTRACT

Renal carcinomas (RC) are uncommonly encountered in feline medicine. Limited information regarding clinical presentation and postoperative outcomes is available. The purpose of this multi-institutional, retrospective study was to describe the presenting features and clinical outcomes of cats with RC undergoing nephrectomy. Thirty-six client-owned cats were included. Medical records from participating institutions were searched to identify cats that had a histopathologic diagnosis of RC and underwent nephrectomy from January 2001 to October 2021. The most common presenting complaints were weight loss (36.1%) and hyporexia (30.6%). Based on preoperative imaging and intraoperative findings, eight cats had suspected metastasis at the time of surgery (22.2%). Twenty-eight cats survived to discharge (77.8%). Median progression free interval (PFI) could not be determined, as only six cats developed suspected recurrence (16.7%) and seven cats developed suspected metastasis (19.4%). The all-cause median survival time (MST) was 203 days (95% confidence interval [CI]: 84, 1379 days). When cases that died prior to discharge were excluded, MST increased to 1217 days (95% CI: 127, 1641 days). One-year, two-year, and three-year survival rates were all 40.4%. Neither renal tumour histologic subtype nor the presence of preoperative azotemia, anaemia, erythrocytosis, haematuria, or suspected metastasis at diagnosis were found to influence survival. For cats surviving to discharge, prolonged survival times were possible. Further studies are necessary to elucidate other potential prognostic factors, the utility of postoperative adjuvant treatment, and to identify cats at-risk of mortality in the perioperative period.


Subject(s)
Carcinoma, Renal Cell , Cat Diseases , Kidney Neoplasms , Cats , Animals , Carcinoma, Renal Cell/surgery , Carcinoma, Renal Cell/veterinary , Retrospective Studies , Treatment Outcome , Nephrectomy/veterinary , Kidney Neoplasms/surgery , Kidney Neoplasms/veterinary , Cat Diseases/surgery
2.
Proc Natl Acad Sci U S A ; 113(17): 4800-5, 2016 Apr 26.
Article in English | MEDLINE | ID: mdl-27071094

ABSTRACT

The sexual blood stage of the human malaria parasite Plasmodium falciparum undergoes remarkable biophysical changes as it prepares for transmission to mosquitoes. During maturation, midstage gametocytes show low deformability and sequester in the bone marrow and spleen cords, thus avoiding clearance during passage through splenic sinuses. Mature gametocytes exhibit increased deformability and reappear in the peripheral circulation, allowing uptake by mosquitoes. Here we define the reversible changes in erythrocyte membrane organization that underpin this biomechanical transformation. Atomic force microscopy reveals that the length of the spectrin cross-members and the size of the skeletal meshwork increase in developing gametocytes, then decrease in mature-stage gametocytes. These changes are accompanied by relocation of actin from the erythrocyte membrane to the Maurer's clefts. Fluorescence recovery after photobleaching reveals reversible changes in the level of coupling between the membrane skeleton and the plasma membrane. Treatment of midstage gametocytes with cytochalasin D decreases the vertical coupling and increases their filterability. A computationally efficient coarse-grained model of the erythrocyte membrane reveals that restructuring and constraining the spectrin meshwork can fully account for the observed changes in deformability.


Subject(s)
Erythrocyte Deformability , Erythrocytes/ultrastructure , Life Cycle Stages , Microtubules/ultrastructure , Models, Biological , Plasmodium falciparum/ultrastructure , Actins/ultrastructure , Computer Simulation , Cytoskeleton/ultrastructure , Spectrin/ultrastructure
3.
Mol Microbiol ; 98(6): 1101-14, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26304012

ABSTRACT

The malaria parasite Plasmodium falciparum dramatically remodels its host red blood cell to enhance its own survival, using a secretory membrane system that it establishes outside its own cell. Cisternal organelles, called Maurer's clefts, act as a staging point for the forward trafficking of virulence proteins to the red blood cell (RBC) membrane. The Ring-EXported Protein-1 (REX1) is a Maurer's cleft resident protein. We show that inducible knockdown of REX1 causes stacking of Maurer's cleft cisternae without disrupting the organization of the knob-associated histidine-rich protein at the RBC membrane. Genetic dissection of the REX1 sequence shows that loss of a repeat sequence domain results in the formation of giant Maurer's cleft stacks. The stacked Maurer's clefts are decorated with tether-like structures and retain the ability to dock onto the RBC membrane skeleton. The REX1 mutant parasites show deficient export of the major virulence protein, PfEMP1, to the red blood cell surface and markedly reduced binding to the endothelial cell receptor, CD36. REX1 is predicted to form a largely α-helical structure, with a repetitive charge pattern in the repeat sequence domain, providing potential insights into the role of REX1 in Maurer's cleft sculpting.


Subject(s)
Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism , Virulence Factors/chemistry , Virulence Factors/metabolism , CD36 Antigens/metabolism , DNA, Protozoan , Erythrocyte Membrane/metabolism , Erythrocytes/parasitology , Gene Knockdown Techniques , Humans , Mutation , Plasmodium falciparum/genetics , Protein Structure, Tertiary , Protein Transport , Proteins/chemistry , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Repetitive Sequences, Nucleic Acid , Virulence Factors/genetics
4.
PLoS Biol ; 13(4): e1002132, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25901609

ABSTRACT

Successful control of falciparum malaria depends greatly on treatment with artemisinin combination therapies. Thus, reports that resistance to artemisinins (ARTs) has emerged, and that the prevalence of this resistance is increasing, are alarming. ART resistance has recently been linked to mutations in the K13 propeller protein. We undertook a detailed kinetic analysis of the drug responses of K13 wild-type and mutant isolates of Plasmodium falciparum sourced from a region in Cambodia (Pailin). We demonstrate that ART treatment induces growth retardation and an accumulation of ubiquitinated proteins, indicative of a cellular stress response that engages the ubiquitin/proteasome system. We show that resistant parasites exhibit lower levels of ubiquitinated proteins and delayed onset of cell death, indicating an enhanced cell stress response. We found that the stress response can be targeted by inhibiting the proteasome. Accordingly, clinically used proteasome inhibitors strongly synergize ART activity against both sensitive and resistant parasites, including isogenic lines expressing mutant or wild-type K13. Synergy is also observed against Plasmodium berghei in vivo. We developed a detailed model of parasite responses that enables us to infer, for the first time, in vivo parasite clearance profiles from in vitro assessments of ART sensitivity. We provide evidence that the clinical marker of resistance (delayed parasite clearance) is an indirect measure of drug efficacy because of the persistence of unviable parasites with unchanged morphology in the circulation, and we suggest alternative approaches for the direct measurement of viability. Our model predicts that extending current three-day ART treatment courses to four days, or splitting the doses, will efficiently clear resistant parasite infections. This work provides a rationale for improving the detection of ART resistance in the field and for treatment strategies that can be employed in areas with ART resistance.


Subject(s)
Artemisinins/pharmacology , Plasmodium falciparum/physiology , Stress, Physiological , Animals , Dose-Response Relationship, Drug , Drug Resistance , Genome, Protozoan , Mutation , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics
5.
Int J Parasitol ; 44(12): 893-9, 2014 Oct 15.
Article in English | MEDLINE | ID: mdl-25161101

ABSTRACT

Recent reports demonstrate that failure of artemisinin-based antimalarial therapies is associated with an altered response of early blood stage Plasmodium falciparum. This has led to increased interest in the use of pulse assays that mimic clinical drug exposure for analysing artemisinin sensitivity of highly synchronised ring stage parasites. We report a methodology for the reliable execution of drug pulse assays and detail a synchronisation strategy that produces well-defined tightly synchronised ring stage cultures in a convenient time-frame.


Subject(s)
Antimalarials/pharmacology , Artemisinins/pharmacology , Parasitic Sensitivity Tests/methods , Plasmodium falciparum/drug effects , Drug Resistance , Plasmodium falciparum/growth & development , Schizonts/drug effects
6.
Anal Chem ; 86(9): 4379-86, 2014 May 06.
Article in English | MEDLINE | ID: mdl-24694036

ABSTRACT

New diagnostic modalities for malaria must have high sensitivity and be affordable to the developing world. We report on a method to rapidly detect and quantify different stages of malaria parasites, including ring and gametocyte forms, using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FT-IR) and partial least-squares regression (PLS). The absolute detection limit was found to be 0.00001% parasitemia (<1 parasite/µL of blood; p < 0.008) for cultured early ring stage parasites in a suspension of normal erythrocytes. Future development of universal and robust calibration models can significantly improve malaria diagnoses, leading to earlier detection and treatment of this devastating disease.


Subject(s)
Erythrocytes/parasitology , Plasmodium/isolation & purification , Animals , Multivariate Analysis , Reproducibility of Results , Spectroscopy, Fourier Transform Infrared
7.
BMC Biol ; 11: 67, 2013 Jun 13.
Article in English | MEDLINE | ID: mdl-23763941

ABSTRACT

BACKGROUND: The carbon metabolism of the blood stages of Plasmodium falciparum, comprising rapidly dividing asexual stages and non-dividing gametocytes, is thought to be highly streamlined, with glycolysis providing most of the cellular ATP. However, these parasitic stages express all the enzymes needed for a canonical mitochondrial tricarboxylic acid (TCA) cycle, and it was recently proposed that they may catabolize glutamine via an atypical branched TCA cycle. Whether these stages catabolize glucose in the TCA cycle and what is the functional significance of mitochondrial metabolism remains unresolved. RESULTS: We reassessed the central carbon metabolism of P. falciparum asexual and sexual blood stages, by metabolically labeling each stage with 13C-glucose and 13C-glutamine, and analyzing isotopic enrichment in key pathways using mass spectrometry. In contrast to previous findings, we found that carbon skeletons derived from both glucose and glutamine are catabolized in a canonical oxidative TCA cycle in both the asexual and sexual blood stages. Flux of glucose carbon skeletons into the TCA cycle is low in the asexual blood stages, with glutamine providing most of the carbon skeletons, but increases dramatically in the gametocyte stages. Increased glucose catabolism in the gametocyte TCA cycle was associated with increased glucose uptake, suggesting that the energy requirements of this stage are high. Significantly, whereas chemical inhibition of the TCA cycle had little effect on the growth or viability of asexual stages, inhibition of the gametocyte TCA cycle led to arrested development and death. CONCLUSIONS: Our metabolomics approach has allowed us to revise current models of P. falciparum carbon metabolism. In particular, we found that both asexual and sexual blood stages utilize a conventional TCA cycle to catabolize glucose and glutamine. Gametocyte differentiation is associated with a programmed remodeling of central carbon metabolism that may be required for parasite survival either before or after uptake by the mosquito vector. The increased sensitivity of gametocyte stages to TCA-cycle inhibitors provides a potential target for transmission-blocking drugs.


Subject(s)
Life Cycle Stages , Malaria, Falciparum/parasitology , Mitochondria/metabolism , Parasites/growth & development , Parasites/metabolism , Plasmodium falciparum/growth & development , Plasmodium falciparum/metabolism , Animals , Citric Acid Cycle/drug effects , Erythrocytes/drug effects , Erythrocytes/parasitology , Fluoroacetates/pharmacology , Gas Chromatography-Mass Spectrometry , Glucose/metabolism , Glutamine/metabolism , Humans , Life Cycle Stages/drug effects , Magnetic Resonance Spectroscopy , Mitochondria/drug effects , Models, Biological , Parasites/drug effects , Plasmodium falciparum/drug effects , Reproduction, Asexual/drug effects
8.
Cell Microbiol ; 15(8): 1401-18, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23421990

ABSTRACT

The human malaria parasite, Plasmodium falciparum, modifies the red blood cells (RBCs) that it infects by exporting proteins to the host cell. One key virulence protein, P. falciparum Erythrocyte Membrane Protein-1 (PfEMP1), is trafficked to the surface of the infected RBC, where it mediates adhesion to the vascular endothelium. We have investigated the organization and development of the exomembrane system that is used for PfEMP1 trafficking. Maurer's cleft cisternae are formed early after invasion and proteins are delivered to these (initially mobile) structures in a temporally staggered and spatially segregated manner. Membrane-Associated Histidine-Rich Protein-2 (MAHRP2)-containing tether-like structures are generated as early as 4 h post invasion and become attached to Maurer's clefts. The tether/Maurer's cleft complex docks onto the RBC membrane at ~20 h post invasion via a process that is not affected by cytochalasin D treatment. We have examined the trafficking of a GFP chimera of PfEMP1 expressed in transfected parasites. PfEMP1B-GFP accumulates near the parasite surface, within membranous structures exhibiting a defined ultrastructure, before being transferred to pre-formed mobile Maurer's clefts. Endogenous PfEMP1 and PfEMP1B-GFP are associated with Electron-Dense Vesicles that may be responsible for trafficking PfEMP1 from the Maurer's clefts to the RBC membrane.


Subject(s)
Erythrocytes/parasitology , Plasmodium falciparum/pathogenicity , Protein Transport/physiology , Protozoan Proteins/physiology , Cells, Cultured , Erythrocyte Membrane/parasitology , Erythrocyte Membrane/physiology , Erythrocytes/pathology , Green Fluorescent Proteins , Host-Parasite Interactions/physiology , Humans , In Vitro Techniques , Plasmodium falciparum/physiology
9.
J Cell Sci ; 125(Pt 8): 2053-63, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22328505

ABSTRACT

The most virulent of the human malaria parasites, Plasmodium falciparum, undergoes a remarkable morphological transformation as it prepares itself for sexual reproduction and transmission via mosquitoes. Indeed P. falciparum is named for the unique falciform or crescent shape of the mature sexual stages. Once the metamorphosis is completed, the mature gametocyte releases from sequestration sites and enters the circulation, thus making it accessible to feeding mosquitoes. Early ultrastructural studies showed that gametocyte elongation is driven by the assembly of a system of flattened cisternal membrane compartments underneath the parasite plasma membrane and a supporting network of microtubules. Here we describe the molecular composition and origin of the sub-pellicular membrane complex, and show that it is analogous to the inner membrane complex, an organelle with structural and motor functions that is well conserved across the apicomplexa. We identify novel crosslinking elements that might help stabilize the inner membrane complex during gametocyte development. We show that changes in gametocyte morphology are associated with an increase in cellular deformability and postulate that this enables the gametocytes to circulate in the bloodstream without being detected and removed by the mechanical filtering mechanisms in the spleen of the host.


Subject(s)
Intracellular Membranes/metabolism , Malaria, Falciparum/parasitology , Plasmodium falciparum/growth & development , Actins/metabolism , Cell Membrane/metabolism , Germ Cells/growth & development , Germ Cells/metabolism , Humans , Myosins/metabolism , Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism
10.
Mol Microbiol ; 81(4): 982-93, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21696460

ABSTRACT

The malaria parasite Plasmodium falciparum assembles knob structures underneath the erythrocyte membrane that help present the major virulence protein, P. falciparum erythrocyte membrane protein-1 (PfEMP1). Membranous structures called Maurer's clefts are established in the erythrocyte cytoplasm and function as sorting compartments for proteins en route to the RBC membrane, including the knob-associated histidine-rich protein (KAHRP), and PfEMP1. We have generated mutants in which the Maurer's cleft protein, the ring exported protein-1 (REX1) is truncated or deleted. Removal of the C-terminal domain of REX1 compromises Maurer's cleft architecture and PfEMP1-mediated cytoadherance but permits some trafficking of PfEMP1 to the erythrocyte surface. Deletion of the coiled-coil region of REX1 ablates PfEMP1 surface display, trapping PfEMP1 at the Maurer's clefts. Complementation of mutants with REX1 partly restores PfEMP1-mediated binding to the endothelial cell ligand, CD36. Deletion of the coiled-coil region or complete deletion of REX1 is tightly associated with the loss of a subtelomeric region of chromosome 2, encoding KAHRP and other proteins. A KAHRP-green fluorescent protein (GFP) fusion expressed in the REX1-deletion parasites shows defective trafficking. Thus, loss of functional REX1 directly or indirectly ablates the assembly of the P. falciparum virulence complex at the surface of host erythrocytes.


Subject(s)
Membrane Proteins/metabolism , Peptides/metabolism , Plasmodium falciparum/genetics , Plasmodium falciparum/metabolism , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Virulence Factors/metabolism , CD36 Antigens/metabolism , Cell Adhesion , Endothelial Cells/metabolism , Erythrocytes/parasitology , Genetic Complementation Test , Humans , Protein Transport , Sequence Deletion
11.
Proc Natl Acad Sci U S A ; 108(28): 11405-10, 2011 Jul 12.
Article in English | MEDLINE | ID: mdl-21709259

ABSTRACT

Combination regimens that include artemisinin derivatives are recommended as first line antimalarials in most countries where malaria is endemic. However, the mechanism of action of artemisinin is not fully understood and the usefulness of this drug class is threatened by reports of decreased parasite sensitivity. We treated Plasmodium falciparum for periods of a few hours to mimic clinical exposure to the short half-life artemisinins. We found that drug treatment retards parasite growth and inhibits uptake of hemoglobin, even at sublethal concentrations. We show that potent artemisinin activity is dependent on hemoglobin digestion by the parasite. Inhibition of hemoglobinase activity with cysteine protease inhibitors, knockout of the cysteine protease falcipain-2 by gene deletion, or direct deprivation of host cell lysate, significantly decreases artemisinin sensitivity. Hemoglobin digestion is also required for artemisinin-induced exacerbation of oxidative stress in the parasite cytoplasm. Arrest of hemoglobin digestion by early stage parasites provides a mechanism for surviving short-term artemisinin exposure. These insights will help in the design of new drugs and new treatment strategies to circumvent drug resistance.


Subject(s)
Antimalarials/pharmacology , Artemisinins/pharmacology , Hemoglobins/metabolism , Plasmodium falciparum/drug effects , Plasmodium falciparum/metabolism , Animals , Biological Transport, Active , Cysteine Endopeptidases/deficiency , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/metabolism , Endocytosis/drug effects , Erythrocytes/parasitology , Gene Deletion , Genes, Protozoan , Host-Parasite Interactions/drug effects , Humans , Malaria, Falciparum/blood , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Parasitemia/blood , Parasitemia/drug therapy , Parasitemia/parasitology , Plasmodium falciparum/genetics , Plasmodium falciparum/growth & development
12.
Cytometry A ; 77(3): 253-63, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20091670

ABSTRACT

The malaria parasite, Plasmodium falciparum, develops within human erythrocytes, consuming host hemoglobin to support its own growth. Reactive oxygen species (superoxide and hydrogen peroxide) are by-products of hemoglobin digestion and are believed to exert significant oxidative stress on the parasite. We have characterized a cell permeant, far red fluorescent nucleic acid-binding dye, SYTO 61, that can be used to distinguish between uninfected and infected erythrocytes in a flow cytometric format. The spectral properties of SYTO 61 make it suitable for use in combination with the fluorescent reactive oxygen species reporter 5-(and-6)-chloromethyl-2',7'-dichlorodihydro-fluorescein diacetate acetyl ester. We have used this probe combination to measure oxidative stress in different stages of live P. falciparum. Low levels of the oxidized, fluorescent form of the reporter (2',7'-dichlorofluorescein, DCF) are detected in ring stage parasites; the DCF signal increases as the intraerythrocytic parasite matures into the trophozoite stage where active hemoglobin digestion occurs. Treatment of infected erythrocytes with the cysteine protease inhibitor, E-64, which inhibits hemoglobin digestion, decreases the DCF signal. We show that E-64 prevents schizont rupture but also causes delayed lethal effects when ring stage cultures are exposed to the drug. We also examined cultures of parasites in erythrocytes harboring 98% catalase inactivation and found no effect on growth and only a modest increase in DCF oxidation.


Subject(s)
Erythrocytes/cytology , Flow Cytometry/methods , Fluorescent Dyes/pharmacology , Malaria/parasitology , Oxidative Stress , Plasmodium falciparum/metabolism , Animals , Artemisinins/pharmacology , Catalase/metabolism , Chloroquine/pharmacology , Cysteine Proteases/metabolism , Erythrocytes/metabolism , Humans , Models, Biological , Nucleic Acids/chemistry , Oxygen/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...